These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3379429)

  • 21. Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid.
    Hårdemark HG; Persson L; Bolander HG; Hillered L; Olsson Y; Påhlman S
    Stroke; 1988 Sep; 19(9):1140-4. PubMed ID: 3413812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Usefulness of determining the level of neuron-specific enolase (NSE) in the cerebrospinal fluid as a biochemical indicator of the extent of cerebral ischemic stroke. Experimental study of the rat model of stroke].
    Kotwica Z; Persson L; Hârdemark HG; Pâhlman S
    Neurol Neurochir Pol; 1989; 23(3):198-202. PubMed ID: 2634819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Two cases of Creutzfeldt-Jakob disease with high neuron-specific enolase level in cerebrospinal fluid].
    Jimi T; Wakayama Y; Shibuya S; Hara H; Sagawa F; Hashizume Y
    Rinsho Shinkeigaku; 1989 Jan; 29(1):118-21. PubMed ID: 2663293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophrenia.
    Egan MF; el-Mallakh RS; Suddath RL; Lohr JB; Bracha HS; Wyatt RJ
    Psychiatry Res; 1992 Aug; 43(2):187-95. PubMed ID: 1357702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction.
    Selakovic V; Raicevic R; Radenovic L
    J Clin Neurosci; 2005 Jun; 12(5):542-7. PubMed ID: 15921910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients.
    Shen ZX; Ding Q; Wei CZ; Ding MC; Meng JM
    Acta Neurol Scand; 1993 Jan; 87(1):19-24. PubMed ID: 8424308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid neurone-specific enolase in mitochondrial encephalomyopathies.
    Finsterer J; Exner M; Rumpold H
    Metab Brain Dis; 2005 Mar; 20(1):81-6. PubMed ID: 15918553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children.
    Rodríguez-Núñez A; Cid E; Eirís J; Rodríguez-García J; Camiña F; Rodríguez-Segade S; Castro-Gago M
    Brain Dev; 1999 Jan; 21(1):16-9. PubMed ID: 10082247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A clinical study on neuron-specific enolase activities in cerebrospinal fluid of neonates].
    Inoue S
    No To Hattatsu; 1992 Nov; 24(6):548-53. PubMed ID: 1419167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An enzyme immunoassay for neuron-specific enolase in cerebrospinal fluid.
    Orlino EN; Olmstead CE; Lazareff JA; Peacock WJ; Fisher RS; Fluharty AL
    Biochem Mol Med; 1997 Jun; 61(1):41-6. PubMed ID: 9232195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid enolase in stroke.
    Hay E; Royds JA; Davies-Jones GA; Lewtas NA; Timperley WR; Taylor CB
    J Neurol Neurosurg Psychiatry; 1984 Jul; 47(7):724-9. PubMed ID: 6747647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental brain ischemia: neuron-specific enolase level in cerebrospinal fluid as an index of neuronal damage.
    Steinberg R; Gueniau C; Scarna H; Keller A; Worcel M; Pujol JF
    J Neurochem; 1984 Jul; 43(1):19-24. PubMed ID: 6726246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The value of neuron specific enolase (NSE) in patients with brain tumors].
    Taomoto K; Kokunai T; Okuda T; Tamaki N; Matsumoto S; Hashimoto N
    No To Shinkei; 1987 Feb; 39(2):169-73. PubMed ID: 3828153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid in long-lasting delirium compared with Alzheimer's dementia.
    Caplan GA; Kvelde T; Lai C; Yap SL; Lin C; Hill MA
    J Gerontol A Biol Sci Med Sci; 2010 Oct; 65(10):1130-6. PubMed ID: 20530241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid and serum neuron-specific enolase concentrations in a normal population.
    Casmiro M; Maitan S; De Pasquale F; Cova V; Scarpa E; Vignatelli L;
    Eur J Neurol; 2005 May; 12(5):369-74. PubMed ID: 15804267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder.
    Nygaard O; Langbakk B; Romner B
    Scand J Clin Lab Invest; 1998 May; 58(3):183-6. PubMed ID: 9670341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid of patients with senile dementia of Alzheimer's type shows an increased inhibition of alpha-chymotrypsin.
    Licastro F; Davis LJ; Morini MC; Cucinotta D; Savorani G
    Alzheimer Dis Assoc Disord; 1994; 8(4):241-9. PubMed ID: 7888154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF neuron-specific enolase after methohexital activation during electrocorticography.
    Rabinowicz AL; Correale JD; Couldwell WT; DeGiorgio CM
    Neurology; 1994 Jun; 44(6):1167-9. PubMed ID: 8208418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of cerebrospinal fluid neuron-specific enolase and S-100b protein in Guillain-Barré syndrome.
    Mokuno K; Kiyosawa K; Sugimura K; Yasuda T; Riku S; Murayama T; Yanagi T; Takahashi A; Kato K
    Acta Neurol Scand; 1994 Jan; 89(1):27-30. PubMed ID: 8178624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease.
    Allen SJ; Dawbarn D; Wilcock GK
    Brain Res; 1988 Jun; 454(1-2):275-81. PubMed ID: 3409011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.